Targeted therapy at the end of life for patients with lung cancer
10.1089/jpm.2010.0084
Saved in:
Main Authors: | Wong, A.S., Teo, C., Lim, S.-W., Wong, E., Soo, R.A., Chan, N. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/115311 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Targeted therapy at the end of life in advanced cancer patients
by: Soh, T.I.P., et al.
Published: (2014) -
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer
by: Tsui, D.W.Y, et al.
Published: (2020) -
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
by: Soo, R.A., et al.
Published: (2014) -
Lung cancer response to gefitinib, then erlotinib, then gefitinib again
by: Wong, A.S., et al.
Published: (2014) -
Targeting SALL4 by entinostat in lung cancer
by: Yong, K.J, et al.
Published: (2020)